Senior insider sale
Chief Medical Officer at ROCKET PHARMACEUTICALS, INC. — senior position signals high conviction
$55.6K
17.05K shares
What this filing means
SCHWARTZ JONATHAN DAVID plans to sell 17.05K shares of ROCKET PHARMACEUTICALS, INC. valued at approximately $55.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/13/2026ACC: 0001959173-26-000992
Officer· Chief Medical Officer
Since Jan 2019
17.05K
Shares to sell
$55.6K
Approx. market value
14.51K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/11/2026
14.51KTotal acquired14.51K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/11/2026 | Restricted Stock Vesting Compensation | 14.51K | — |
| Total | 14.51K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.54K
Market value
$7.6K
11/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
14.51K
Market value
$48.1K
2/13/2026
Total
Units
17.05K
Value
$55.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/18/2025 | 2.54K | $7.6K | — | Completed |
| Planned — Approximate Date | ||||
2/13/2026 | 14.51K | $48.1K | NASDAQ | Planned |
| Total | 17.05K | $55.6K | ||